Palonosetron

From WikiAnesthesia
Revision as of 01:02, 30 March 2022 by Chris Rishel (talk | contribs) (Created page with "{{Infobox drug reference | trade_names = | drug_class = | drug_class_color = | uses = | contraindications = | routes = | dosage = |dosage_calculation=palonosetron}} Provide a brief summary of this drug here. ==Uses<!-- Describe uses of the drug. If appropriate, add subsections for each indication. -->== ==Contraindications<!-- List contraindications and precautions for use of the drug. -->== ===Absolute contraindications<!-- List absolute contraindications for...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Palonosetron
Clinical data
Dosage
Adult dosing
  • 0.075 mg IV
  • 1.5 mL of 0.05 mg/mL
Indication 
Postoperative nausea & vomiting
Route 
Intravenous
Preparation 
0.05 mg/mL
  1. Kovac AL, Eberhart L, Kotarski J, Clerici G, Apfel C; Palonosetron 04-07 Study Group. A randomized, double-blind study to evaluate the efficacy and safety of three different doses of palonosetron versus placebo in preventing postoperative nausea and vomiting over a 72-hour period. Anesth Analg. 2008 Aug;107(2):439-44. doi: 10.1213/ane.0b013e31817abcd3. PMID: 18633021.
Pharmacodynamics
Pharmacokinetics
Physical and chemical data
Article quality
Editor rating
Unrated
User likes
0

Provide a brief summary of this drug here.

Uses

Contraindications

Absolute contraindications

Precautions

Pharmacology

Pharmacodynamics

Mechanism of action

Adverse effects

Pharmacokinetics

Chemistry and formulation

History

References

Top contributors: Chris Rishel

Retrieved from "https://wikianesthesia.org/w/index.php?title=Palonosetron&oldid=4393"